Brought to you by:
New diversity, equity and inclusion pillar signals additional priority for SVS Foundation
The Society for Vascular Surgery (SVS) Foundation has been guided by the three long-term pillars of research and innovation, community vascular care and patient education, and disease prevention. Recently, the Foundation added a fourth pillar—for diversity, equity and inclusion (DEI)…
Chocolate Touch DCB for treatment of peripheral arterial disease receives FDA approval
Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter developed by TriReme Medical for the treatment of patients with peripheral arterial disease (PAD) in the…
NESVS Robert R. Linton Lecture features complex aortic masterclass from Europe
World-leading aortic surgeon Stéphan Haulon, MD, from the Aortic Centre at Hôpital Marie Lannelongue in Paris, France, took attendees of the 2022 New England Society for Vascular Surgery (NESVS) annual meeting on a whirlwind, 15-year journey through the evolution of…
SOOVC sub-section introduces two awards
The Society for Vascular Surgery’s sub-section for those who provide service in outpatient settings has created two professional development opportunities for its members, a research grant and a presentation award to present already completed research. Applications for the Sub-Section on…
CMS: An update on quality measures for vascular surgery
An upcoming national reporting change/addition from the Centers for Medicare and Medicaid Services (CMS) includes three important elements of which Society for Vascular Surgery (SVS) members should be aware.The SVS Performance Measures Committee (PMC) represents SVS member interests regarding national…
SVS adds ‘service’ criterion to Distinguished Fellows process
The Society for Vascular Surgery (SVS) has added service to the Society as an important component of its Distinguished Fellows process, an honor annually bestowed upon a handful of members. This accolade goes to Active, International or Senior vascular-surgeon members…
First data from BEST-CLI bring surgical bypass into the forefront of discussion for patients with high-quality great saphenous vein
The first results from the BEST-CLI randomized controlled trial (RCT) of 1,830 patients show that surgical bypass with adequate single-segment great saphenous vein (GSV) is a more effective revascularization strategy for patients with chronic limb-threatening ischemia (CLTI) who are deemed…
SVS asking members to expand diversity in Nominating Committee
The Society for Vascular Surgery (SVS) will ask voting-eligible members to consider three revisions to article X of the SVS bylaws that would take a step toward change on the SVS Nominating Committee. In the past several years, the membership…
Amplifi vein dilation system continues to show promise following latest first-in-human study update
An update from the first-in-human study assessing the Amplifi vein dilation system (Artio Medical) was delivered by Surendra Shenoy, MD, from Washington University School of Medicine in St Louis, during the first-ever late-breaking clinical trials session at this year’s Venous Endovascular…
Virtual visits versus in-person: Telemedicine study detects ‘substantial’ cost savings for patients
Virtual consultations appear comparable to care received in-person when it comes to clinical outcomes as well as patient and practitioner satisfaction, a systematic review and meta-analysis of all primary studies evaluating virtual patient visits in vascular surgery has demonstrated. “The…